skip to Main Content

Marapharm Commences Trading on US-Based OTC

Les Kjosness, President & CEO, is pleased to announce Marapharm Ventures Inc. (the ’Company’), has commenced trading on the OTC Venture Marketplace in the United States. Our symbol on the OTC is MRPHF. The Company’s objective is to attain a listing on the OTCQB board. OTCQB is for both entrepreneurial and development stage U.S. as well as international companies. The OTCQB is a platform for broker dealers to trade unlisted stocks electronically. The platform supports an open network of competing broker-dealers that provides investors with prices in over 10,000 securities. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. These standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. “The OTC listing marks a further step in our commitment to enhance international recognition and facilitate liquidity of our common shares to broaden our international shareholder base,” says Kjosness.


About Marapharm Ventures Inc.
Marapharm was formed to create a global entity by pursuing commercial ventures in the medical marijuana business. The Company’s original project is the construction of brand new facilities on 11 acres in British Columbia’s Okanagan Valley with expansion plans in place to meet strategic advantages for growth and market penetration. Marapharm is currently in the process of its application for an MMPR license. In May 2015, we announced the purchase of 5.9 acres in the Apex Industrial Park, located in North Las Vegas, Nevada. The Company has a provisional grow licence in place and will build up to a 70,000 square foot medical marijuana facility. Completed building plans were revised and re-submitted for permitting. In addition to the Las Vegas acquisition, Marapharm has entered into an LOI with the same business corporation for a 90-day exclusive negotiation rights and the right of first refusal for two additional Nevada Medical Marijuana licences, one grow operation and a medical dispensary licence in Washington State and one medical dispensary licence in California.

On behalf of the Board
“Les Kjosness”
President & Director

For further information please visit the Company`s website at

The CSE has neither approved nor disapproved the accuracy of this news release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities – that could cause actual results to differ materially from the

Company’s expectations are disclosed in the Companies’ documents filed from time to time on SEDAR (see Readers are cautioned not to place undue reliance on these forward – looking statements, which speak only as of the date of this news release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward – looking statements, whether as a result of new information, future events or otherwise.

Back To Top